BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15198948)

  • 1. Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia.
    Roman-Gomez J; Jimenez-Velasco A; Castillejo JA; Agirre X; Barrios M; Navarro G; Molina FJ; Calasanz MJ; Prosper F; Heiniger A; Torres A
    Blood; 2004 Oct; 104(8):2492-8. PubMed ID: 15198948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis.
    Roman-Gomez J; Jimenez-Velasco A; Agirre X; Prosper F; Heiniger A; Torres A
    J Clin Oncol; 2005 Oct; 23(28):7043-9. PubMed ID: 16192589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5' CpG island hypermethylation is associated with transcriptional silencing of the p21(CIP1/WAF1/SDI1) gene and confers poor prognosis in acute lymphoblastic leukemia.
    Roman-Gomez J; Castillejo JA; Jimenez A; Gonzalez MG; Moreno F; Rodriguez Mdel C; Barrios M; Maldonado J; Torres A
    Blood; 2002 Apr; 99(7):2291-6. PubMed ID: 11895758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermethylation of CpG island in the promoter region of CALCA in acute lymphoblastic leukemia with central nervous system (CNS) infiltration correlates with poorer prognosis.
    Paixão VA; Vidal DO; Caballero OL; Vettore AL; Tone LG; Ribeiro KB; Lopes LF
    Leuk Res; 2006 Jul; 30(7):891-4. PubMed ID: 16712930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA hypermethylation of cell cycle (p15 and p16) and apoptotic (p14, p53, DAPK and TMS1) genes in peripheral blood of leukemia patients.
    Bodoor K; Haddad Y; Alkhateeb A; Al-Abbadi A; Dowairi M; Magableh A; Bsoul N; Ghabkari A
    Asian Pac J Cancer Prev; 2014; 15(1):75-84. PubMed ID: 24528084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias.
    Chim CS; Wong AS; Kwong YL
    Ann Hematol; 2003 Dec; 82(12):738-42. PubMed ID: 14513284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant promoter hypermethylation of selected apoptotic genes in childhood acute lymphoblastic leukemia among North Indian population.
    Nikbakht M; Jha AK; Malekzadeh K; Askari M; Mohammadi S; Marwaha RK; Kaul D; Kaur J
    Exp Oncol; 2017 Mar; 39(1):57-64. PubMed ID: 28361856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CpG island methylator phenotype redefines the prognostic effect of t(12;21) in childhood acute lymphoblastic leukemia.
    Roman-Gomez J; Jimenez-Velasco A; Agirre X; Castillejo JA; Navarro G; Calasanz MJ; Garate L; San Jose-Eneriz E; Cordeu L; Prosper F; Heiniger A; Torres A
    Clin Cancer Res; 2006 Aug; 12(16):4845-50. PubMed ID: 16914570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor prognosis in acute lymphoblastic leukemia may relate to promoter hypermethylation of cancer-related genes.
    Roman-Gomez J; Jimenez-Velasco A; Barrios M; Prosper F; Heiniger A; Torres A; Agirre X
    Leuk Lymphoma; 2007 Jul; 48(7):1269-82. PubMed ID: 17613754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of aberrant promoter hypermethylation of CpG islands in patients with diffuse large B-cell lymphomas.
    Amara K; Trimeche M; Ziadi S; Laatiri A; Hachana M; Korbi S
    Ann Oncol; 2008 Oct; 19(10):1774-86. PubMed ID: 18539616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional silencing of the Dickkopfs-3 (Dkk-3) gene by CpG hypermethylation in acute lymphoblastic leukaemia.
    Roman-Gomez J; Jimenez-Velasco A; Agirre X; Castillejo JA; Navarro G; Barrios M; Andreu EJ; Prosper F; Heiniger A; Torres A
    Br J Cancer; 2004 Aug; 91(4):707-13. PubMed ID: 15226763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein expression of a triad of frequently methylated genes, p73, p57Kip2, and p15, has prognostic value in adult acute lymphocytic leukemia independently of its methylation status.
    Bueso-Ramos C; Xu Y; McDonnell TJ; Brisbay S; Pierce S; Kantarjian H; Rosner G; Garcia-Manero G
    J Clin Oncol; 2005 Jun; 23(17):3932-9. PubMed ID: 15851765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia.
    Agirre X; Román-Gómez J; Jiménez-Velasco A; Garate L; Montiel-Duarte C; Navarro G; Vázquez I; Zalacain M; Calasanz MJ; Heiniger A; Torres A; Minna JD; Prósper F
    Oncogene; 2006 Mar; 25(13):1862-70. PubMed ID: 16314841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant methylation in promoter-associated CpG islands of multiple genes in relapsed childhood acute lymphoblastic leukemia.
    Matsushita C; Yang Y; Takeuchi S; Matsushita M; Van Dongen JJ; Szczepanski T; Bartram CR; Seo H; Koeffler HP; Taguchi H
    Oncol Rep; 2004 Jul; 12(1):97-9. PubMed ID: 15201966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG island methylator phenotype and its relationship with prognosis in adult acute leukemia patients.
    Fu HY; Wu DS; Zhou HR; Shen JZ
    Hematology; 2014 Sep; 19(6):329-37. PubMed ID: 24164743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant DNA methylation of a cell cycle regulatory pathway composed of P73, P15 and P57KIP2 is a rare event in children with acute lymphocytic leukemia.
    Canalli AA; Yang H; Jeha S; Hoshino K; Sanchez-Gonzalez B; Brandt M; Pierce S; Kantarjian H; Issa JP; Garcia-Manero G
    Leuk Res; 2005 Aug; 29(8):881-5. PubMed ID: 15978938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
    Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
    Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WNT5A, a putative tumour suppressor of lymphoid malignancies, is inactivated by aberrant methylation in acute lymphoblastic leukaemia.
    Roman-Gomez J; Jimenez-Velasco A; Cordeu L; Vilas-Zornoza A; San Jose-Eneriz E; Garate L; Castillejo JA; Martin V; Prosper F; Heiniger A; Torres A; Agirre X
    Eur J Cancer; 2007 Dec; 43(18):2736-46. PubMed ID: 18032022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation status of Wnt signaling pathway genes affects the clinical outcome of Philadelphia-positive acute lymphoblastic leukemia.
    Martin V; Agirre X; Jiménez-Velasco A; José-Eneriz ES; Cordeu L; Gárate L; Vilas-Zornoza A; Castillejo JA; Heiniger A; Prósper F; Torres A; Roman-Gomez J
    Cancer Sci; 2008 Sep; 99(9):1865-8. PubMed ID: 18549404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent and simultaneous epigenetic inactivation of TP53 pathway genes in acute lymphoblastic leukemia.
    Vilas-Zornoza A; Agirre X; Martín-Palanco V; Martín-Subero JI; San José-Eneriz E; Garate L; Álvarez S; Miranda E; Rodríguez-Otero P; Rifón J; Torres A; Calasanz MJ; Cruz Cigudosa J; Román-Gómez J; Prósper F
    PLoS One; 2011 Feb; 6(2):e17012. PubMed ID: 21386967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.